Yes, it's a very large decrease in use. In 2003, the medication called malarone became licensed. Starting in 2003, we started to see a decrease in mefloquine use. It had been sitting around 85% of prescriptions for anti-malarial medications, and it has decreased down to less than 5% today. Malarone use, which was maybe 5% or 10% at that time, has now increased to between 80% and 85% of the anti-malarial medication that we are prescribing.
On February 23rd, 2017. See this statement in context.